Peer-reviewedCC BYCureus
Cannabidiol (CBD) for Pain: A Narrative Review of Evidence to Date
6 affiliations
- 1School of Pharmacy, Temple University, Philadelphia, USA
- 2Clinical Research, NEMA Research, Naples, USA
- 3Clinical Pharmacy, Mid Atlantic PharmaTech Consultants, Ventnor City, USA
- 4Emergency Medicine, Northwell Health, New Hyde Park, USA
- 5Research, Fondazione Paolo Procacci, Rome, ITA
- 6Medicine, Minia University, Cairo, EGY
Related
- Low-energy extracorporeal shock wave therapy for interstitial cystitis/bladder pain syndrome: mechanisms, evidence, and translational perspectives—a narrative review
- Evaluating Acupuncture for Chemotherapy-Induced Peripheral Neuropathic Pain: A Narrative Review of Clinical Evidence and Mechanistic Perspectives
- Rebound pain after regional anesthesia in orthopedic surgery: current evidence and clinical implications – a narrative review
- Precision Orthobiologics for Chronic Musculoskeletal Pain: Matching Biology, Pathology, and Patient Phenotype-A Narrative Review of Current Evidence and Future Directions in Regenerative Pain Medicine.
- Pathophysiology of pain in acute pancreatitis: A narrative review
BibTeX
@article{raffa2026cannabidiol,
title = {{Cannabidiol (CBD) for Pain: A Narrative Review of Evidence to Date}},
author = {Robert B Raffa and Joseph V Pergolizzi and Frank Breve and Eugene Vortsman and Giustino Varrassi and Salah N EL-Tallawy},
journal = {Cureus},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13676070},
note = {CC BY},
}
RIS
TY - JOUR
TI - Cannabidiol (CBD) for Pain: A Narrative Review of Evidence to Date
AU - Robert B Raffa
AU - Joseph V Pergolizzi
AU - Frank Breve
AU - Eugene Vortsman
AU - Giustino Varrassi
AU - Salah N EL-Tallawy
PY - 2026
DA - 2026/10/19
JO - Cureus
UR - https://europepmc.org/article/PMC/PMC13676070
SN - 2168-8184
ER -